Smaltis at the Key Industry Events of Autumn 2025! From medical devices to biotherapies, from fundamental research to industrial production, we meet project leaders to better understand microbiology needs and build new collaborations.
Over the past few weeks, our teams have had the pleasure of taking part in several major events dedicated to innovation in healthcare: BIOPC (Lyon) – an unmissable event for bioproduction market, La Rentrée du DM (Besançon) – focused on medical device challenges, Innovative Therapies Days (Besançon) – where biotherapies and microbiology meet, La Journée Collaborative Lyonbiopôle (Lyon) – a catalyst for R&D partnerships, I4ID (Lyon) – centered on innovations in infectiology.
These events offer valuable opportunities to exchange ideas with researchers, industry representatives, start-ups and institutions, and to deepen our understanding of the current challenges in health, production, and regulation.
The diversity of these events highlights the many ways microbiology adds value:
In research, through the development and validation of innovative microbial models to better understand microorganism–host interactions.
In production, through reliable, standardized solutions to control, secure, and qualify biological products, biotherapies, or medical devices.
Each meeting is an opportunity for us to listen, learn, and identify new collaboration topics where our expertise can help turn ideas into concrete solutions.
These valuable exchanges strengthen our conviction that microbiology lies at the heart of many key issues — from therapeutic efficacy to product safety and industrial performance.
We warmly thank everyone who took the time to meet and exchange with us during these events — and we look forward to continuing these discussions around future collaborative projects.
News and articles
Meeting the Innovation
Smaltis at the Key Industry Events of Autumn 2025! From medical devices to biotherapies, from fundamental research to industrial production, we meet project leaders to better understand microbiology needs and build new collaborations.
New Offer Structure: 2 Business Units Supporting Your Projects
At Smaltis, our ambition remains unchanged: bringing microbiological excellence to your innovations.
To better address the diversity of your needs, we have structured our offer around 2 complementary Business Units, true pillars of our scientific and technical commitment.
Malassezia: Cultivating the Invisible – A Challenge Met
Some yeasts are particularly resistant… especially Malassezia restricta.
This lipophilic yeast, naturally present on human skin, is involved in various imbalances of the skin microbiota, notably those linked to dandruff or seborrheic dermatitis. But cultivating it in the laboratory is no easy task!
Once upon a time was cheese, a high place of communication between fungi and bacteria.
Attracted by the smell of French cheeses, a team from Tufts University published work on how, in Camembert, Roquefort and other festivities, bacteria use compounds produced by fungi and adapt their behavior.
Once upon a time, the English bacteriologist Ernest Hankin demonstrated for the first time the presence of anti-bacterial entities in the waters of Indian rivers, putting humanity on the path to a promising anti-infectious therapy that is more relevant than ever.
Smaltis attends the 34th edition of the ECCMID international congress, renamed ESCMID Global, in Barcelona from April 27 to 30, 2024. This clinical microbiology and infectious diseases event is one of the largest and most important congresses in the field of infection, bringing together over 16,000 participants from all over the world to contribute to the dissemination of scientific knowledge.
Smaltis attends the Sanofi Vaccines R&D Day, organized by Sanofi in partnership with Lyonbiopôle, Enosis Santé and Polepharma!
This event aims to foster partnerships around 5 themes: antimicrobial approaches, therapeutic vaccines and antibodies, mucosal or skin delivery of vaccines, immunology, and antigen design. Quite a program!
Cédric Muller will be present at this event, which will take place on April 11, 2024, at 14 Espace Henry Vallée in Lyon.
Smaltis is delighted to be taking part in the 7th edition of Microbiota & Health Day, organized by Lyonbiopôle and Alliance Promotion Microbiote, on March 26, 2024 in Lyon. The aim of this day is to bring together academic, clinical and industrial players to discuss topical issues that are driving innovation in the field of microbiota and their impact on health.
Smaltis is happy to participate to the 8th edition of AMR Conference in Basel from March 6th to 7th 2024, a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and specific challenges faced by the innovation ecosystem in bringing new antimicrobial treatments and diagnostics to the market.
The year 2024 marks the 10th anniversary (already!) of the Smaltis adventure! 10 years of microbiology, 10 years of molecular biology, 10 years of passion, 10 years of twists and turns, 10 years of growth, 10 years of self-reflection, 10 years of continuous improvement, 10 years of scientific spirit, 10 years of ambition, 10 years of collaboration, 10 years of human relationships…
It was necessary to celebrate this milestone, and not just by blowing out the candles.
All articles